T 0066/20 of 30.06.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T006620.20230630
- Date of decision
- 30 June 2023
- Case number
- T 0066/20
- Petition for review of
- -
- Application number
- 09800069.8
- IPC class
- G01N 33/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- IDENTIFICATION OF SUBJECTS BEING SUSCEPTIBLE TO ANTI-ANGIOGENESIS THERAPY
- Applicant name
- F. Hoffmann-La Roche AG
Roche Diagnostics GmbH - Opponent name
- Mathys & Squire LLP
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention R 103(1)(a)European Patent Convention R 111(2)Rules of procedure of the Boards of Appeal 2020 Art 011
- Keywords
- Substantial procedural violation - appealed decision not sufficiently reasoned
Remittal to the opposition division
Remittal - fundamental deficiency in the opposition proceedings
Reimbursement of appeal fee - equitable by reason of a substantial procedural violation - Catchword
- -
- Cited cases
- T 1713/20
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division.
3. The appeal fee is reimbursed.